-
-
-
-
-
-
-
Citi Reiterates Sell Rating on Dr. Reddy\'s Laboratories (DRRD:IN) (RDY)
-
-
-
-
-
-
-
Dr. Reddy’s Q1 FY24 Financial Results
-
-
-
-
-
-
-
Athenex (ATNX) option IV low at 20
-
-
-
-
-
-
-
Dr. Reddy's Laboratories and MediCane Health Announce the Launch of Medical Cannabis Products in Germany
-
-
-
-
-
-
-
Aditxt Signs a Transaction Agreement to Acquire AiPharma, Rights Holder of Antiviral Tablet Avigan/Reeqonus/Qifenda Used in the Treatment of Over 1.5 Million COVID-19 Patients Outside the U.S. and Can
-
-
-
-
-
-
-
Exelixis (EXEL) and Aurigene Announce Promising Preclinical Data to Be Presented at ENA Symposium Support Clinical Development of Novel CDK7 Inhibitor
-
-
-
-
-
-
-
Upsher-Smith Laboratories Completes Acquisition Of Two Treatments For Acute Migraine In Adults
-
1,157,559 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

